A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc.

Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...

Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer ...

Discover how a tiny RNA molecule serves as a molecular switch in viral infections, providing insights into phage biology.

Researchers at the Kanazawa University Graduate School of Medical Sciences report in PLOS Pathogens a novel role for the ...

Marine bacteria are key to determining whether carbon is recycled near the ocean surface or transported to deeper waters, but ...

A newly identified virus–cell hybrid structure allows viruses to spread faster and more aggressively by hitching a ride on ...

Investigators from the laboratory of Derek Walsh, Ph.D., professor of Microbiology-Immunology, have discovered how human cytomegalovirus rewires intracellular mechanisms to control the movement of the ...